acut
respiratori
infect
ari
lead
caus
morbid
hospit
mortal
among
children
accord
world
health
organ
acut
respiratori
infect
respons
million
annual
death
children
mainli
affect
patient
year
old
higher
incid
lowincom
countri
ari
mainli
caus
wide
rang
virus
bacteria
virus
isol
case
common
pathogen
respiratori
syncyti
viru
rsv
b
influenza
flu
b
c
parainfluenza
piv
type
coronaviru
rhinoviru
classic
pneumonia
h
influenza
type
b
commonli
isol
bacteria
throat
nasopharyng
specimen
patient
ari
howev
resourcelimit
countri
atyp
bacteria
mycoplasma
pneumonia
chlamydia
pneumonia
bordetella
pertussi
play
import
role
ari
detect
patient
although
numer
pathogen
associ
ari
clinic
manifest
similar
regardless
caus
agent
thu
laboratori
identif
etiolog
agent
key
order
give
proper
treatment
avoid
overus
antibiot
moreov
ari
due
atyp
bacteri
infect
becom
global
concern
especi
reemerg
lowincom
countri
simultan
infect
viru
bacteria
speci
becom
obstacl
clinician
preval
significantli
increas
studi
discov
coinfect
case
addit
coinfect
associ
longer
hospit
period
wors
clinic
outcom
increas
mortal
highlight
import
molecular
etiolog
confirm
bordetella
pertussi
repres
persist
caus
morbid
mortal
children
account
estim
million
case
death
worldwid
previou
studi
conduct
children
probabl
diagnosi
pertussi
peruvian
hospit
report
preval
pertussi
case
case
without
identifi
pathogen
henc
comprehens
etiolog
analysi
requir
main
object
studi
detect
presenc
respiratori
virus
influenzaa
influenzab
rsva
rsvb
adenoviru
atyp
bacteria
mycoplasma
pneumonia
chlamydia
pneumonia
via
polymeras
chain
reaction
sampl
peruvian
children
yearsold
previous
analyz
b
pertussi
secondari
data
analysi
perform
previou
crosssect
studi
conduct
januari
juli
peruvian
hospit
instituto
nacion
de
salud
del
hospit
edgardo
rebagliati
martin
hospit
de
emergencia
hospit
nacion
cayetano
heredia
hospit
region
de
cajamarca
origin
studi
enrol
children
year
old
admit
pediatr
ward
probabl
pertussi
case
howev
origin
studi
patient
includ
final
analysi
probabl
case
defin
patient
present
paroxysm
cough
inspiratori
whoop
posttuss
vomit
set
acut
cough
ill
durat
absenc
anoth
like
diagnosi
patient
yearold
apnea
without
cyanosi
also
consid
patient
chronic
pulmonari
condit
cardiac
diseas
immunodefici
exclud
patient
receiv
antibiot
day
prior
enrol
also
exclud
fig
studi
includ
total
children
year
old
hospit
probabl
diagnosi
pertussi
requir
comprehens
etiolog
identif
sampl
analyz
via
pcr
follow
etiolog
influenzaa
influenzab
rsva
rsvb
adenoviru
parainfluenza
viru
parainfluenza
viru
parainfluenza
viru
mycoplasma
pneumonia
chlamydia
pneumonia
studi
approv
ethic
committe
universidad
peruana
de
ciencia
aplicada
parent
caregiv
sign
written
consent
previou
studi
includ
section
grant
investig
permiss
possibl
futur
use
sampl
could
given
extens
origin
research
nasopharyng
sampl
obtain
insert
swab
nostril
parallel
palat
minitip
cultur
direct
bectondickinson
microbiolog
system
md
usa
second
swab
posterior
pharyng
tonsillar
area
viral
culturett
bectondickinson
microbiolog
system
md
usa
nasal
pharyng
swab
place
tube
contain
viral
transport
medium
minim
essenti
medium
fetal
bovin
serum
amphotericin
b
neomycin
two
aliquot
fresh
specimen
store
use
posterior
analysi
respiratori
virus
detect
atyp
pathogen
pcr
rnadna
extract
perform
serum
sampl
high
pure
rna
isol
kit
roch
appli
scienc
mannheim
germani
accord
manufactur
instruct
viral
rnadna
obtain
extract
elut
nucleasefre
water
process
store
use
rtpcr
influenzaa
influenzab
rsva
rsvb
adenoviru
viru
perform
use
bhq
quencher
probe
nm
nm
primer
final
volum
five
microlit
extract
rna
combin
master
mix
rtpcr
condit
cycl
process
perform
light
instrument
data
analyz
softwar
roch
diagnost
deutschlandmannheim
germani
primer
probe
influenza
b
describ
selvaraju
et
al
rsva
rsvb
describ
liu
w
et
al
adenoviru
describ
heim
et
al
case
parainfluenza
viru
parainfluenza
viru
parainfluenza
primer
condit
rtpcr
describ
coira
et
al
polymeras
chain
reaction
perform
templat
dna
polymeras
gotaq
promega
madison
wisconsin
usa
primer
conditio
use
mycoplasma
pneumonia
chlamydia
pneumonia
descrit
del
vall
et
al
primer
condit
use
bordetella
pertussi
describ
castillo
et
al
amplifi
product
recov
gel
purifi
spinprep
gel
dna
kit
san
diego
ca
sent
commerci
sequenc
macrogen
korea
databas
gener
microsoft
microsoft
corpor
california
usa
data
export
statacorp
colleg
station
texa
usa
quantit
variabl
describ
frequenc
percentag
group
associ
establish
pearson
correl
analysi
r
result
present
scatter
matrix
ellips
plot
confid
total
patient
year
old
probabl
diagnosi
b
ertussi
studi
thouroughli
specif
etiolog
identif
studi
popul
infant
month
old
slightli
higher
number
male
group
infant
day
monthsold
group
monthsold
predomin
close
follow
group
monthsold
addit
file
tabl
previou
studi
case
bordetella
pertussi
confirm
via
pcr
leav
potenti
sampl
without
etiolog
identif
thu
analyz
presenc
influenzaa
flua
influenzab
flub
rsva
rsvb
adenoviru
adv
parainfluenza
viru
parainfluenza
viru
parainfluenza
viru
mycoplasma
pneumonia
chlamydia
pneumonia
common
pathogen
isol
adenoviru
follow
bordetella
pertussi
mycoplasma
pneumonia
flub
addit
file
tabl
identif
infecti
agent
made
possibl
establish
remark
coinfect
present
patient
thu
case
infect
due
singl
infecti
agent
presenc
adv
b
pertussi
follow
pneumonia
furthermor
preval
infecti
agent
accumul
children
month
age
addit
file
tabl
indic
infect
children
case
coinfect
stand
consider
addit
file
tabl
coinfect
found
involv
differ
infecti
agent
frequent
coinfect
agent
involv
agent
frequenc
frequent
associ
bacterialvir
coinfect
combin
bordetellaadv
mycoplasmaadv
common
involv
report
respect
howev
bordetellamycoplasma
associ
reduc
addit
file
tabl
addit
interest
note
associ
coinfect
increas
frequenc
infecti
agent
chlamydia
flub
rsva
observ
addit
file
tabl
compar
regard
vaccin
statu
posit
case
unvaccin
howev
major
children
two
month
age
unknown
vaccin
statu
observ
patient
posit
b
pertussi
mark
decreas
observ
children
receiv
least
one
dose
vaccin
preval
addit
file
tabl
popul
common
clinic
symptom
regist
admiss
vomit
whoop
short
breath
follow
fever
cyanosi
wide
spread
distribut
symptom
distribut
observ
patient
symptom
individu
assess
base
etiolog
group
pathogen
symptom
present
group
exampl
vomit
commonli
report
among
children
flua
rsva
b
pertussi
addit
file
tabl
howev
difficulti
establish
clear
clinic
symptom
associ
infecti
causal
agent
due
high
frequenc
coinfect
therefor
addit
file
tabl
record
clinic
symptom
case
infect
singl
agent
associ
clinic
symptom
shown
fig
thu
clear
nonassoci
observ
mycoplasma
flub
adv
bordetella
happen
flub
bordetella
adv
nonassoci
mean
infecti
agent
could
identifi
take
account
clinic
symptom
children
shown
addit
file
tabl
common
complic
acut
bronchial
obstruct
syndrom
abo
pneumonia
popul
respect
abo
frequent
complic
among
patient
posit
sampl
rsva
flua
adv
pneumonia
c
pneumonia
b
pertussi
addit
file
tabl
howev
complic
children
affect
singl
infecti
agent
analyz
clearli
demonstr
abo
also
complic
flub
addit
noteworthi
abo
occur
neg
case
addit
file
tabl
final
season
distribut
describ
specif
microorgan
posit
sampl
adv
mycoplasma
pneumonia
observ
across
whole
studi
period
contrari
b
pertussi
case
detect
may
march
rsva
chlamydia
mostli
detect
march
may
howev
distribut
observ
follow
year
fig
ari
common
caus
morbid
mortal
children
remain
major
concern
especi
affect
children
year
old
lowincom
countri
unfortun
inform
regard
epidemiolog
still
limit
peru
recent
year
evid
pertussi
resurg
latin
america
despit
introduct
vaccin
bacterium
highli
contagi
virul
half
infect
children
one
year
whoop
cough
requir
hospit
peru
nation
immun
program
administ
combin
pentaval
vaccin
dpt
hvb
hib
month
reinforc
month
year
thu
conduct
previou
studi
peruvian
children
probabl
diagnosi
pertussi
report
bordetella
pertussi
preval
howev
classic
present
pertussi
proven
enough
achiev
definit
diagnosi
laboratori
test
utmost
import
etiolog
confirm
avoid
overdiagnosi
light
possibl
coinfect
patient
without
etiolog
identif
previou
studi
conduct
new
comprehens
analysi
detect
viral
atyp
bacteri
etiolog
patient
total
sampl
analyz
children
year
old
probabl
diagnosi
pertussi
common
pathogen
isol
adv
sampl
follow
b
pertussi
previou
analysi
although
studi
conduct
patient
ari
highli
suspici
pertussi
diagnosi
studi
children
ari
identifi
adv
one
preval
etiolog
although
viral
bacteri
preval
may
vari
wide
depend
popul
characterist
interestingli
popul
children
highli
suspici
clinic
diagnosi
pertussi
despit
whoop
present
patient
adv
common
etiolog
isol
furthermor
great
number
patient
adv
infect
present
clinic
symptom
common
among
patient
pertussi
whoop
short
breath
vomit
similarli
recent
studi
report
gastrointestin
symptom
difficulti
breath
among
common
type
present
children
addit
adv
histor
identifi
major
caus
pertussislik
syndrom
result
likelihood
pertussi
misdiagnosi
absenc
laboratori
confirm
way
shown
patient
infect
adv
bpertussi
singl
infecti
agent
similar
symptom
fig
also
import
highlight
presenc
mycoplasma
pneumonia
chlamydia
pneumonia
among
patient
previou
studi
children
ari
report
similar
preval
mycoplasma
pneumonia
chlamydia
pneumonia
respect
demonstr
high
preval
atyp
bacteria
among
peruvian
children
ari
result
current
studi
also
make
noteworthi
clinic
manifest
mycoplasma
pneumonia
flub
adv
b
pertussi
distinguish
infect
due
infecti
agent
alon
howev
coinfect
symptom
undestingu
see
tabl
addit
previou
studi
coinfect
bacteria
virus
also
frequent
present
sampl
coinfect
common
combin
associ
mycoplasma
pneumonia
vrsa
frequent
one
observ
patient
surprisingli
studi
observ
coinfect
sampl
viralbacteri
associ
frequent
commonli
detect
coinfect
involv
bordetella
pertussisadv
mycoplasma
pneumoniaeadv
frequenc
respect
anoth
studi
children
although
patient
communityacquir
pneumonia
also
report
coinfect
pneumonia
common
bacteria
detect
associ
viru
thu
avoid
underdiagnosi
pertussi
consid
patient
cough
especi
chronic
even
pneumonia
document
anoth
common
coinfect
b
pertussi
flub
present
patient
although
viralbacteri
coinfect
commonli
associ
wors
clinic
cours
longer
hospit
recent
investig
report
similar
clinic
outcom
infant
hospit
b
pertussi
anoth
respiratori
viru
coinfect
howev
noteworthi
attent
given
b
pertussi
adv
coinfect
infant
studi
compar
infant
rsv
rsvb
pertussi
coinfect
report
similar
diseas
sever
howev
patient
coinfect
clearli
need
respiratori
care
nutrit
support
consequ
patient
rsva
pertussi
present
cyanosi
requir
advanc
respiratori
support
variat
rate
pattern
coinfect
patient
ari
may
relat
season
geograph
factor
studi
intend
describ
detect
pathogen
season
distribut
even
though
abl
describ
clear
pattern
worth
mention
high
preval
adv
pneumonia
across
studi
period
well
increas
preval
b
pertussi
studi
limit
mention
previou
studi
due
studi
design
abl
establish
causal
pathogen
isol
sampl
patient
clinic
present
addit
miss
sampl
abl
perform
etiolog
analysi
sampl
previou
studi
abl
perform
etiolog
analysi
sampl
previou
studi
adit
still
controversi
pcr
alon
use
confirmatori
method
pneumonia
diagnosi
commerci
pcr
test
high
specif
current
method
choic
direct
pathogen
detect
howev
studi
recommend
pcr
alon
replac
serolog
combin
could
good
screen
test
reliabl
accur
diagnosi
pneumonia
moreov
recent
studi
suggest
posit
pcr
serolog
pneumonia
may
unabl
differenti
asymptomat
carriag
symptomat
infect
date
avail
publish
inform
regard
etiolog
preval
ari
peruvian
children
still
limit
despit
high
incid
pertussi
especi
vulner
popul
infant
date
establish
etiolog
diagnosi
low
incom
countri
still
challeng
moreov
relationship
clinic
sever
coinfect
respiratori
pathogen
remain
inconclus
studi
among
first
one
describ
multipl
viral
bacteri
etiolog
patient
high
clinic
suspicion
pertussi
investig
conduct
order
understand
role
pathogen
peruvian
children
